A molecule produced by cancer cells can shield the brain from Alzheimer’s disease in mice. For decades, researchers have ...

Cleveland researchers achieve full cognitive recovery in mice, offering new hope for dementia patients.

High blood sugar spikes after meals could be a contributing factor to Alzheimer's risk, according to a new study that gives ...

The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest, with recent ...

A blood test, combined with an ultrathin material derived from graphite, could significantly advance efforts to detect ...

The finger-prick blood test employs a plasma separation card, designed to cut costs and simplify testing procedures.

Researchers have successfully reversed advanced Alzheimer's in mice, achieving full cognitive recovery by restoring the brain ...

Alzheimer’s affects over two million Americans and is the leading cause of dementia. It is progressive, incurable, and driven ...

David Diebold took on the HURT100 race three years after his father was diagnosed with a form of Alzheimer’s disease.

The drug will advance to a multiple ascending dose study, with later plans to initiate a Phase II/III trial.

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel ...

The Rutgers Robert Wood Johnson Medical School has been chosen as one of about 40 sites to see how well benfotiamine can slow ...